Oncology.

Intro -- QR code -- Title page -- Copyright -- Preface -- About the companion website -- Part 1 Introduction to oncology -- 1 What is cancer? -- Epidemiological perspective -- How to read a histology report -- A histopathological definition of cancer: is it malignant or benign? -- Cancer epidemiology -- Cancer charities -- 2 The scientific basis of cancer -- The hallmarks of cancer -- How to acquire the six capabilities (enabling hallmarks) -- Additional capabilities of cancers (emerging hallmarks) -- Genome instability -- Genetic causes of cancer -- Environmental causes of cancer -- Worldwide contributions to cancer -- 3 The principles of cancer treatment -- Appropriate care -- Cancer staging -- Performance status -- Prognosis: it is not cancer, is it doc? -- Surgical oncology -- Radiotherapy -- Chemotherapy -- Endocrine therapy -- Immunological therapy -- Targeted therapies -- Clinical trials -- Palliative care -- 4 Cancer and people -- Social and psychological aspects of cancer -- Unconventional treatments -- Ethics -- Sociology of oncology -- Part 2 Types of cancer -- 5 Breast cancer -- Epidemiology -- Presentation and screening -- Diagnosis -- Staging and grading -- Treatment -- Carcinoma in situ -- Paget's disease of the nipple -- Male breast cancer -- 6 Central nervous system cancers -- Epidemiology -- Aetiology -- Pathology -- Presentation -- Investigation and staging -- Treatment -- Prognosis -- 7 Oesophageal cancer -- Epidemiology and pathogenesis -- Prevention -- Presentation -- Staging and grading -- Treatment -- Prognosis -- 8 Gastric cancer -- Epidemiology and pathogenesis -- Presentation -- Staging and pathology -- Treatment -- Survival -- 9 Hepatobiliary cancer -- Epidemiology -- Pathogenesis -- Prevention -- Presentation -- Staging and grading -- Treatment -- Prognosis -- 10 Pancreatic cancer -- Epidemiology -- Pathogenesis.

Presentation -- Staging and grading -- Treatment -- Prognosis -- Pancreatic endocrine tumours -- 11 Colorectal cancer -- Epidemiology -- Pathogenesis -- Presentation -- Diagnosis -- Staging and grading -- Treatment -- Management of metastatic disease -- Screening -- 12 Kidney cancer -- Epidemiology -- Pathogenesis -- Presentation -- Outpatient diagnosis -- Staging and grading -- Treatment -- Anti-angiogenic therapy -- Targeted therapy -- Prognosis -- 13 Bladder cancer -- Epidemiology -- Pathogenesis -- Presentation -- Staging and grading -- Treatment -- Prognosis -- 14 Prostate cancer -- Epidemiology -- Pathogenesis -- Presentation -- Staging and grading -- Treatment -- Prognosis -- Screening -- 15 Testis cancer -- Epidemiology -- Pathogenesis -- Presentation -- Staging and grading -- Treatment -- Prognosis -- 16 Gestational trophoblastic disease -- Epidemiology -- Pathogenesis -- Presentation -- Treatment -- Prognosis -- 17 Cervical cancer -- Epidemiology -- Pathogenesis -- Screening -- Prevention (vaccination) -- Presentation -- Outpatient diagnosis -- Staging and grading -- Treatment -- Cervical intraepithelial neoplasia -- Prognosis -- Terminal care -- 18 Endometrial cancer -- Epidemiology -- Pathogenesis -- Presentation -- Treatment and prognosis -- 19 Ovarian cancer -- Epidemiology -- Pathogenesis -- Screening -- Presentation -- Staging and grading -- Treatment -- Prognosis -- 20 Head and neck cancers -- Epidemiology -- Pathogenesis -- Clinical presentation -- Treatment -- Prognosis -- Salivary gland tumours -- 21 Thyroid cancer -- Epidemiology -- Pathogenesis -- Presentation -- Investigations -- Treatment -- Prognosis -- 22 Adrenal cancers -- Epidemiology of adrenal cortical cancers -- Presentation of adrenal cortical cancers -- Investigations of adrenal cortical cancers -- Initial treatment of adrenal cortical cancers.

Treatment of metastatic or locally advanced adrenal cortical cancer -- Prognosis of adrenal cortical cancers -- Adrenal medullary tumours -- 23 Carcinoid tumours -- Presentation -- Investigations -- Treatment -- Prognosis -- 24 Pituitary tumours -- Epidemiology and pathology -- Treatment -- 25 Parathyroid cancers -- Epidemiology and pathology -- Multiple endocrine neoplasia -- Presentation and treatment -- 26 Lung cancer -- Epidemiology -- Smoking and prevention -- Pathogenesis -- Screening -- Presentation -- Pathology -- Staging and grading -- Treatment -- 27 Mesothelioma -- Epidemiology -- Pathogenesis -- Presentation -- Investigations -- Treatment -- Prognosis -- 28 The leukaemias -- Epidemiology -- Pathogenesis -- Presentation -- Investigations and classification -- Treatment -- 29 Hodgkin's lymphoma -- Epidemiology -- Pathogenesis -- Presentation -- Investigations -- Pathology -- Staging -- Treatment and side effects -- Complications of chemotherapy -- 30 Non-Hodgkin's lymphoma -- Epidemiology -- Pathogenesis -- Presentation -- Staging and grading -- Treatment -- 31 Myeloma -- Epidemiology -- Pathogenesis -- Presentation -- Investigations -- Treatment -- 32 Non-melanoma skin tumours -- Epidemiology -- Pathogenesis -- Presentation -- Treatment -- Prognosis -- 33 Melanoma -- Epidemiology -- Pathogenesis -- Presentation -- Staging and grading -- Treatment -- Prognosis -- 34 Paediatric solid tumours -- Epidemiology -- Pathogenesis -- Presentation and management of paediatric solid tumours -- Presentation and management of CNS tumours -- Presentation and management of lymphomas -- Presentation and management of soft tissue sarcomas and bone tumours -- Presentation and management of neuroblastoma -- Presentation and management of Wilms' tumours (nephroblastoma) -- Presentation and management of retinoblastoma.

Presentation and management of liver tumours -- Complications of childhood treatment of cancer -- 35 Cancers in teenagers and young adults -- Epidemiology -- Presentation and management of paediatric solid tumours -- 36 Bone and soft tissue sarcomas -- Epidemiology -- Pathogenesis -- Presentation -- Investigations and management of bone sarcomas -- Treatment of Ewing's sarcomas -- Treatment of osteosarcomas -- Investigations and management of soft tissue sarcomas -- Treatment of soft tissue sarcomas -- 37 Cancer of unknown primary -- Epidemiology and pathogenesis -- Clinical sites of metastatic spread -- Clinical CUP syndromes -- Histopathological characterization -- Use of tumour markers -- Approach to investigation of metastatic disease to establish primary site -- 38 Immunodeficiency-related cancers -- Hereditary or primary immunodeficiency -- Acquired or secondary immunodeficiency -- Tumours in HIV patients -- Tumours in primary immunodeficiency -- Management of immunodeficiency-associated malignancies -- Part 3 The practice of oncology -- 39 Paraneoplastic complications of cancer -- Paraneoplastic endocrine complications -- Paraneoplastic neurological conditions -- Paraneoplastic dermatological conditions -- Cachexia -- 40 Oncological emergencies -- Metabolic disorders -- Tumour lysis syndrome -- Mechanical complications -- Malignant effusions -- Haematological disorders -- Myelosuppression -- Anaemia -- Thrombocytopenia -- 41 End-of-life care -- Pain control -- Care of the dying patient -- The last hours and days -- Bereavement -- The culture of death and dying -- 42 Cancer survivorship -- Index -- EULA.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.